Figure 3. The principle of ‘range ﬁnding’ processes that match HIF prolyl hydroxylation to the rate of
synthesis of HIF and to the capacity of HIF degradation pathways downstream of hydroxylation.
NF-kB, nuclear factor kappa-light-chain-enhancer of activated B cells; mTOR, mammalian target of rapamycin.
